GB8606293D0 - Antigenically active protein - Google Patents

Antigenically active protein

Info

Publication number
GB8606293D0
GB8606293D0 GB868606293A GB8606293A GB8606293D0 GB 8606293 D0 GB8606293 D0 GB 8606293D0 GB 868606293 A GB868606293 A GB 868606293A GB 8606293 A GB8606293 A GB 8606293A GB 8606293 D0 GB8606293 D0 GB 8606293D0
Authority
GB
United Kingdom
Prior art keywords
active protein
antigenically active
antigenically
protein
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB868606293A
Other versions
GB2172704B (en
GB2172704A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Research Development Corp UK
Original Assignee
National Research Development Corp UK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858506970A external-priority patent/GB8506970D0/en
Application filed by National Research Development Corp UK filed Critical National Research Development Corp UK
Publication of GB8606293D0 publication Critical patent/GB8606293D0/en
Publication of GB2172704A publication Critical patent/GB2172704A/en
Application granted granted Critical
Publication of GB2172704B publication Critical patent/GB2172704B/en
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/571—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1217—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell
GB08606293A 1985-03-18 1986-03-13 Antigenically active protein and its use in the diagnosis of gonorrhoea Expired GB2172704B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858506970A GB8506970D0 (en) 1985-03-18 1985-03-18 Antigenically active protein
US78972585A 1985-10-21 1985-10-21

Publications (3)

Publication Number Publication Date
GB8606293D0 true GB8606293D0 (en) 1986-04-16
GB2172704A GB2172704A (en) 1986-09-24
GB2172704B GB2172704B (en) 1988-07-13

Family

ID=26288992

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08606293A Expired GB2172704B (en) 1985-03-18 1986-03-13 Antigenically active protein and its use in the diagnosis of gonorrhoea

Country Status (3)

Country Link
EP (1) EP0216841A1 (en)
GB (1) GB2172704B (en)
WO (1) WO1986005592A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0348144B1 (en) * 1988-06-22 1996-01-10 Hygeia Sciences, Inc. Method for treating mucus-containing immunoassay samples
GB8921227D0 (en) * 1989-09-20 1989-11-08 Wellcome Found Antibodies and proteins
WO2009108307A2 (en) * 2008-02-26 2009-09-03 University Of Massachusetts Diagnostic uses of anti-h8 monoclonal antibodies

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4178359A (en) * 1976-10-12 1979-12-11 Hoffmann-La Roche Inc. Immunoassay method
NL7804410A (en) * 1977-05-09 1978-11-13 Merck & Co Inc METHOD FOR DETERMINING THE TITER OF AN ANTI-BODY AGAINST GRAMNEGATIVE BACTERIA, OR FOR DETERMINING THE IDENTITY OF A GRAMNEGATIVE BACTERY AND TEST KIT FOR PERFORMING THE METHOD. 250478 METHOD FOR DETERMINING THE TITER OF AN ANTI-BODY AGAINST GRAM-NEGATIVE BACTERIA, RESPECTIVE- GATIVE BACTERY AND TEST KIT FOR PERFORMANCE
GB2018796B (en) * 1978-03-29 1982-07-28 Ici Ltd Emulsifiable compositions
US4220450A (en) * 1978-04-05 1980-09-02 Syva Company Chemically induced fluorescence immunoassay
US4241045A (en) * 1978-05-15 1980-12-23 Research Corporation Purified antigen to test for Neisseria gonorrheae antibodies
US4332890A (en) * 1978-05-15 1982-06-01 Abbott Laboratories Detection of neisseria gonorrhoeae
US4288557A (en) * 1978-10-12 1981-09-08 Merck & Co., Inc. Antigenic complex from N. gonorrhoeae
US4299916A (en) * 1979-12-26 1981-11-10 Syva Company Preferential signal production on a surface in immunoassays
US4366241A (en) * 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
WO1983003354A1 (en) * 1982-03-30 1983-10-13 Us Army Neisseria gonorrhoeae vaccine

Also Published As

Publication number Publication date
WO1986005592A1 (en) 1986-09-25
GB2172704B (en) 1988-07-13
GB2172704A (en) 1986-09-24
EP0216841A1 (en) 1987-04-08

Similar Documents

Publication Publication Date Title
EP0210461A3 (en) Physiologically active polypeptide buf-3
EP0214818A3 (en) Active compounds
GB8504099D0 (en) Physiologically active substances
AR244662A1 (en) Benzoyl-ureas having insecticide activity
HUT46539A (en) Biologically active copolimers
DE3377654D1 (en) Hypocholesterolemically active protein
ZA861811B (en) Benzoyl-ureas having insecticide activity
GB2177917B (en) Dermatologically active substances
GB8606293D0 (en) Antigenically active protein
GB8506970D0 (en) Antigenically active protein
GB8408766D0 (en) Antigenically active polypeptide
GB8503260D0 (en) Active compounds
GB8503258D0 (en) Active compounds
GB8530312D0 (en) Active compounds
GB8516359D0 (en) Active compounds
GB8516390D0 (en) Active compounds
GB8516391D0 (en) Active compounds
GB8518969D0 (en) Active compounds
GB8520256D0 (en) Active compounds
GB8520620D0 (en) Active compounds
GB8530311D0 (en) Active compounds
GB8529457D0 (en) Active compounds
GB8522492D0 (en) Active compounds
GB8503331D0 (en) Active compounds
GB8511237D0 (en) Active compounds

Legal Events

Date Code Title Description
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19930313